指南与共识衰弱、肌少症与跌倒老年慢病共病管理多重用药

老年与衰弱2型糖尿病指南推荐系统综述

Systematic review of guideline recommendations for older and frail adults with type 2 diabetes mellitus.
指南 / 共识 · Age Ageing · 2024-01-01

多数指南对较健康老年人建议严格HbA1c目标,对衰弱或医学复杂者建议较宽松目标,但药物治疗推荐差异较大且针对衰弱者的推荐相对较少。

要点

  • 较健康老年人多建议严格HbA1c目标,衰弱或医学复杂者建议较宽松目标。
  • 16部指南提供了针对老年和/或衰弱人群的非胰岛素降糖药推荐,主要聚焦低血糖风险最小化。
  • 药物治疗推荐差异较大,针对衰弱个体的推荐比例相对较少。

核心结论

  • 多数糖尿病指南对较健康老年人推荐严格HbA1c目标,对衰弱或医学复杂者推荐较宽松目标。
  • 药物治疗推荐存在显著差异,且针对衰弱个体的推荐比例相对较少。

研究设计与样本

  • 采用AGREE II工具评价纳入指南质量。

主要发现

  • 15部指南给出了针对老年和/或衰弱成人的具体HbA1c目标,多数建议较健康老年人严格目标(<7.0%-7.5%),衰弱或医学复杂者较宽松目标(<8.0%-8.5%)。
  • 10部指南提供了针对老年和/或衰弱人群的胰岛素治疗推荐,16部提供了非胰岛素降糖药推荐,主要聚焦低血糖风险最小化。

关键数值与推荐

  • 较健康老年人严格HbA1c目标:<7.0%-7.5%。
  • 衰弱或医学复杂者较宽松HbA1c目标:<8.0%-8.5%。

临床怎么用

  • 对老年2型糖尿病者应结合衰弱与医学复杂性分层设定HbA1c目标。
  • 药物治疗选择应优先考虑低血糖风险最小化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The application of clinical practice guidelines (CPGs) across the spectrum of individuals living with diabetes can be challenging, particularly in older adults, where factors such as frailty and multimorbidity exacerbate the complexity of management. OBJECTIVE: This systematic review aimed to explore the guidance provided within diabetes CPGs for management of individuals who are older and/or frail, including recommendations for haemoglobin A1C (HbA1c) target and pharmacotherapeutic management. METHODS: A systematic search was completed in Medline and Embase to identify national or international type 2 diabetes CPGs published in the last 10 years. Data extracted included recommendations for HbA1c targets and pharmacotherapy in older and frail adults, frailty screening and deprescribing. Quality of included CPGs was appraised with the AGREE II tool. RESULTS: Twenty-three CPGs were included, within which older adults and frailty were discussed in 21 and 14 CPGs, respectively. Specific HbA1c targets for older and/or frail adults were provided by 15 CPGs, the majority of which suggested a strict target (<7.0%-7.5%) in healthier older adults and a more relaxed target (<8.0%-8.5%) in those who are frail or medically complex. Ten CPGs provided recommendations for insulin therapy and 16 provided recommendations for non-insulin antihyperglycaemic agents that were specific to older and/or frail populations, which primarily focused on minimising risk of hypoglycaemia. CONCLUSION: Most diabetes CPGs recommend strict HbA1c targets in healthier older adults, with more relaxed targets in those living with frailty or medical complexity. However, significant variability exists in pharmacotherapy recommendations and there were proportionately less recommendations for individuals who are frail.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Bolt J, Carvalho V, Lin K, et al. Systematic review of guideline recommendations for older and frail adults with type 2 diabetes mellitus. Age Ageing. 2024. PMID: 39572394. doi:10.1093/ageing/afae259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。